give me top 5 research papers related to hypertension

Reading File

Searching the medical database for top research on hypertension.

search_medical_text

hypertension research landmark studies clinical trials

Diagnosis and Management of Hypertension (HTN) in Primary Care

Page 38

search_medical_text

hypertension blood pressure treatment guidelines evidence

Management of Elevated Blood Pressure and Hypertension

Page 8

GradeResponse

Here are 5 landmark research papers related to hypertension that have significantly shaped clinical practice:

1. SPRINT Trial (2015)

Systolic Blood Pressure Intervention Trial

Published in: New England Journal of Medicine (2015)
Key Finding: Targeting a systolic BP <120 mmHg (intensive control) reduced major cardiovascular events by ~25% and all-cause mortality by ~27% compared to the standard target of <140 mmHg.
Impact: Directly influenced the 2024 ESH/ESC Guidelines recommendation to pursue a systolic BP target of 120–129 mmHg in treated adults (Management of Elevated Blood Pressure and Hypertension, p. 8).

2. Veterans Administration Cooperative Study on Antihypertensive Agents (1967–1970)

Published in: JAMA
Key Finding: One of the earliest landmark RCTs demonstrating that treating hypertension to a diastolic BP <90 mmHg substantially reduced strokes, heart failure, and other cardiovascular events vs. placebo.
Impact: Established the foundational evidence base for antihypertensive treatment, cited by VA/DoD HTN CPG (Diagnosis and Management of Hypertension in Primary Care, p. 38).

3. ALLHAT Trial (2002)

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Published in: JAMA
Key Finding: Thiazide diuretics (chlorthalidone) were at least as effective as ACE inhibitors (lisinopril) and calcium channel blockers (amlodipine) in preventing cardiovascular outcomes and were superior in preventing heart failure.
Impact: Reinforced thiazide diuretics as a first-line therapy in hypertension management.

4. Hypertension Detection and Follow-up Program (HDFP, 1979)

Published in: JAMA
Key Finding: Systematic, stepped-care antihypertensive treatment reduced 5-year all-cause mortality by 17% compared to referred-care in patients with diastolic BP ≥90 mmHg.
Impact: Confirmed broad population-level benefit of treating even mild hypertension; cited in VA/DoD HTN CPG (Diagnosis and Management of Hypertension in Primary Care, p. 38).

5. 2024 ESH Guidelines — Evidence Review (2024)

"Management of Elevated Blood Pressure and Hypertension"

Published in: European Heart Journal
Key Finding: Introduced the new "Elevated BP" category (systolic 120–139 mmHg), shifted the treatment target to systolic 120–129 mmHg for medicated patients, and extended evidence for BP-lowering benefits even below the traditional hypertension threshold in high-CVD-risk individuals (Management of Elevated Blood Pressure and Hypertension, p. 8).
Impact: Represents the most current evidence-based framework for hypertension classification and management globally.

#	Study	Year	Key Takeaway
1	SPRINT	2015	Intensive BP control (<120 mmHg) reduces CV events & mortality
2	VA Cooperative Study	1967–70	First RCT proving antihypertensives reduce CV events
3	ALLHAT	2002	Thiazide diuretics are optimal first-line agents
4	HDFP	1979	Systematic treatment reduces all-cause mortality by 17%
5	2024 ESH Guidelines	2024	New "Elevated BP" category; target SBP 120–129 mmHg

These five studies collectively trace the evolution of hypertension management from proof-of-concept (VA/HDFP) to refined treatment targets (SPRINT, 2024 ESH), and drug selection (ALLHAT).

hello

Hello! How can I help you today?

This is a shared conversation. Sign in to Orris to start your own chat.